This conclusion is consistent with two other studies showing that NanogP8 overexpression alone in transgenic animals is unable to initiate mammary tumor development [58] or Nanog only weakly enhances liver tumorigenesis in a hepatocellular carcinoma reconstitution model [67]. The gene discussed is NANOGP8; the disease is hepatocellular carcinoma.